(Q40147394)

17 September 2017

1 reference

title

Prostaglandins and the cardiovascular system (English)

1 reference

17 September 2017

1

Vane JR

1 reference

17 September 2017

1 May 1983

1 reference

17 September 2017

British Heart Journal

1 reference

17 September 2017

49

1 reference

17 September 2017

5

1 reference

17 September 2017

405-409

1 reference

Eighth Gaddum Memorial Lecture. University of London Institute of Education, December 1980. Biological importance of prostacyclin

17 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481324

Prostacyclin reversal of lethal endotoxemia in dogs

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481324

The effects of prostacyclin (PGI2) on endotoxin shock and endotoxin-induced platelet aggregation in dogs.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481324

Preliminary experience with prostaglandins E1 and I2 in peripheral vascular disease.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481324

Prostacyclin administration during cardiopulmonary bypass in man.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481324

Unstable metabolites of arachidonic acid and their role in haemostasis and thrombosis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481324

Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481324

Successful therapy of advanced arteriosclerosis obliterans with prostacyclin

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481324

Prostacyclin can replace heparin in haemodialysis in dogs

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481324

Circulatory and anti-platelet effects of intravenous prostacyclin in healthy men

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481324

Platelet Dysfunction Associated with Cardiopulmonary Bypass

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481324

Prostacyclin: A Potentially Valuable Agent for Preserving Myocardial Tissue in Acute Myocardial Ischemia

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481324

Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481324

Coronary Vasoconstrictor Effect of Indomethacin in Patients with Coronary-Artery Disease

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481324

Myocardial protection with prostacyclin after lethal endotoxemia

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481324

Prostacyclin in experimental myocardial ischemia: effects on hemodynamics, regional myocardial blood flow, infarct size and mortality

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481324

Salutary effects of prostacyclin in endotoxic shock

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481324

Earlier charcoal haemoperfusion in fulminant hepatic failure

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481324

Prostacyclin: haemodynamic and metabolic effects in patients with coronary artery disease

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481324

Haemostasis disorders in open heart surgery with extracorporeal circulation. Importance of the platelet function and the heparin neutralization

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481324

Effects of intravenous prostacyclin in variant angina.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481324

Clinical use of prostacyclin (PGI2) in ischaemic stroke.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481324

EPOPROSTENOL (PROSTACYCLIN) AND SEVERE ARTERIAL DISEASE

20 August 2018

1 reference

12 December 2020

Prostacyclin deficiency in thrombotic thrombocytopenic purpura

1 reference

12 December 2020

Prostacyclin to prevent platelet activation during charcoal haemoperfusion in fulminant hepatic failure

1 reference

12 December 2020

Cytoprotective actions of prostacyclin during hypoxia in the isolated perfused cat liver

1 reference

12 December 2020

Prostacyclin and prostaglandin E1 for severe idiopathic pulmonary artery hypertension

1 reference

12 December 2020

Treatment of pregnancy hypertension with prostacyclin

1 reference

12 December 2020

Short term suppression of hyperacute renal allograft rejection in presensitised dogs with prostacyclin

1 reference

12 December 2020

Prostacyclin therapy of thrombotic thrombocytopenic purpura

1 reference

12 December 2020

Prostacyclin in central retinal vein occlusion

1 reference

12 December 2020

Intravenous prostacyclin for ischemic ulcers in peripheral artery disease

1 reference

12 December 2020

Prostacyclin for pulmonary hypertension

1 reference

12 December 2020

Biosynthesis of prostacyclin in rat cerebral microvessels and the choroid plexus

1 reference

12 December 2020

Hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent

1 reference

12 December 2020

Safety of coronary arterial prostacyclin infusion

1 reference

12 December 2020

Prostacyclin in extracorporeal circulations

1 reference

12 December 2020

Dialysis without anticoagulants

1 reference

12 December 2020

Successful treatment of Raynaud's Syndrome with prostacyclin

1 reference

12 December 2020

Treatment of chronic kidney transplant rejection with prostacyclin - reduction of platelet deposition in the transplant; prolongation of platelet survival and improvement of transplant function

1 reference

12 December 2020

Treatment of Raynaud's phenomenon by intravenous infusion of prostacyclin (PGI2)

1 reference

12 December 2020

Salvage of the severely ischaemic limb by intra-arterial prostacyclin (PGI2) infusion. A case report

1 reference

12 December 2020

Twenty-four- and 48-hour canine liver preservation by simple hypothermia with prostacyclin

1 reference

12 December 2020

Effect of prostacyclin on fibrinolytic activity in patients with arteriosclerosis obliterans

1 reference

12 December 2020

Influence of blood sampling site and technique on thromboxane concentrations in patients with ischemic heart disease

1 reference

12 December 2020

Prostacyclin therapy in patients with congestive heart failure

1 reference

12 December 2020

[Prostacyclin versus regional heparinisation during haemodialysis (author's transl)]

1 reference

12 December 2020

Administration of prostacyclin prevents ventricular fibrillation following coronary occlusion in conscious dogs

1 reference

12 December 2020

INTERMITTENT EPOPROSTENOL (PROSTACYCLIN) INFUSION IN PATIENTS WITH RAYNAUD'S SYNDROME

1 reference

12 December 2020

Identifiers

DOI

10.1136/HRT.49.5.405

1 reference

17 September 2017

1 reference

PMC publication ID

481324

17 September 2017

PubMed publication ID

6340706

1 reference

PMC publication ID

481324